Pretreatment with EA may be useful in lowering the amount of cerebral infarction and the degree of neuronal death during CIRI by blocking the GluN2B/m-calpain/p38 MAPK pro-apoptotic pathway. The gene discussed is CAPN2; the disease is cerebral infarction.